Validea's Top Information Technology Stocks Based On Warren Buffett

Validea's Patient Investor model, based on Warren Buffett's investment strategy, identifies several top-rated Information Technology stocks. Apple (AAPL) receives a 93% rating, indicating strong interest due to its underlying fundamentals and valuation. Accenture (ACN) is rated at 86%, while Adobe (ADBE), Manhattan Associates (MANH), and EPAM Systems (EPAM) each receive a 72% rating, suggesting some interest based on the same criteria; each company's strengths and weaknesses are assessed against the Buffett-inspired strategy's key tests.

Analysis

Validea's Patient Investor model, replicating Warren Buffett's strategy of identifying firms with long-term predictable profitability, low debt, and reasonable valuations, has highlighted several Information Technology stocks. Apple Inc. (AAPL) achieved a 93% rating, signifying strong model interest, driven by its success in passing all nine screening criteria, including earnings predictability, debt service, return on equity, return on total capital, and free cash flow. Accenture PLC (ACN) also demonstrated strong alignment with the Buffett-style criteria, scoring 86% and passing all fundamental tests, indicating considerable model interest. Conversely, Adobe Inc. (ADBE), Manhattan Associates Inc. (MANH), and EPAM Systems Inc. (EPAM) each garnered a 72% rating, suggesting a more moderate level of interest from the model. Adobe's assessment was impacted by failing the return on equity and return on total capital tests. Manhattan Associates did not meet the model's thresholds for use of retained earnings and initial rate of return. EPAM Systems fell short on the expected return criterion. These specific failures, despite passing other metrics such as earnings predictability, highlight distinct areas of concern according to this particular investment strategy.

Key Decisions for Investors

• Investors employing a Buffett-style, long-term value approach should consider Apple (AAPL) for further investigation, given its 93% Validea model score and clean sweep of all fundamental criteria.
• Accenture (ACN), with its 86% rating and no failed metrics under the model, warrants consideration for portfolios seeking exposure to fundamentally sound IT companies, aligning with the Patient Investor strategy.